Ob/Gyn Updated
Your Web destination for the latest in Evidence based Obstetrics, Gynecology and Women’s health.
Showing posts with label
Talzenna
.
Show all posts
Showing posts with label
Talzenna
.
Show all posts
Wednesday, October 17, 2018
FDA approves PARP inhibitor talazoparib for BCRA-positive, HER2‑negative advanced breast cancer
›
The US Food and Drug Administration (FDA) approved talazoparib (Talzenna, Pfizer Inc.) for patients with advanced BCRA -positive, HER2...
3 comments:
›
Home
View web version
